Hrafnhildur studies disparities in the detection of diabetes and hypertension in primary healthcare
Focusing the thesis on whether detection of type 2 diabetes and hypertension differs across population groups, the aim of Hrafnhildur's doctoral research is to enable a more efficient detection of metabolic risk factors within primary healthcare.
Name: Hrafnhildur Gudjonsdottir
Thesis title: Detection of metabolic factors and type 2 diabetes in Stockholm County
Department of Global Public Health
Research group: Prevention, intervention och mekanismer inom folkhälsa (PRIME Health)
Hello Hrafnhildur!
Please, tell us a bit about your background and what led you to pursue doctoral studies.
I have a background in nutrition from the University of Iceland, which prompted my research interest. After working at the Centre for Epidemiology and Community Medicine (CES) for some time, I had the opportunity to start my doctoral studies.
In short, what is the aim of your research?
My thesis focuses on the detection of type 2 diabetes and hypertension in primary healthcare centres in Stockholm County, and whether detection differs across population groups. It also explores how to simplify processes while increasing detection of metabolic risk factors and type 2 diabetes. The overall aim is to enable a more efficient detection of metabolic risk factors and T2D within primary healthcare.
If any so far – what have been the most surprising or significant findings?
We found in the first study that nearly half of individuals who developed type 2 diabetes in 10 years were undiagnosed. We found no association between socioeconomic status and being diagnosed by healthcare.
What has been the most rewarding part of being a PhD student at KI?
The most rewarding part has been the continuous and stimulating learning process.
Have you had any collaborations that have been particularly important for your development as a researcher?
Yes, multidisciplinary teams within GPH and other KI departments have been extremely valuable, along with other national and international collaborations. I’ve also had the chance to work with different actors, the KI biobank and various register holders.
What advice would you give to new PhD students who are just starting their research journey?
Research rarely follows a linear path, so learning to treat setbacks as learning opportunities is important. Reach out for support to peers and senior researchers in your research group or at GPH. Stay curious, patient and remember that there is a reason why it is called re-search as a wise researcher one’s said.